- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03795844
COMPARISON OF LIVER RETRACTOR FOR INTRATOPERATIVE LIVER DAMAGE (RETRACTOR)
March 19, 2021 updated by: ANIL ERGIN, Fatih Sultan Mehmet Training and Research Hospital
COMPARISON OF LIVER RETRACTOR USED IN LAPAROSCOPIC SLEEVE GASTRECTOMY BY INTRAOPERATIVE LIVER DAMAGE
The frequency of laparoscopic bariatric surgery is increasing day by day.
In these surgeries, the liver masses are also found to be significantly larger due to the high Body Mass Index scores.
It is known that the application of a diet called liver shrinkage protein diet which is applied preoperatively is a method that contributes to the comfort of the surgeon during surgery by reducing the size of the liver.
The large size of the liver narrows the field of view of the surgeon in operation and decreases the comfort of surgery.
One of the most important points that the surgeon must solve during surgery is the exclusion of the left lobe of the liver.
The most commonly used types of liver retractors today; Nathanson retractor, Snowden-Window retractor, Snake retractor, Fan retractor, LIvac retractor and many other retractors.
Some of these retractors require an additional incision under xiphoid, which may lead to an injury risk.
The installation of these retractors also increases the operation time and requires additional time.
Numerous studies have shown that retractors, which are used to rule out liver left lobe during surgery, cause liver damage.
However, in order to reveal His angle in the esophageal-gastric composition, hepatic left lobe exclusion is mandatory.
Therefore, it is necessary to determine and use the retractor type which causes the least damage between the liver retractors.
In our study, it was aimed to reveal three types of liver retractors in our hospital in different cases and to reveal the type of trocar that causes the least amount of liver damage.
Study Overview
Status
Completed
Conditions
Detailed Description
During laparoscopic upper abdominal surgery, the operative view is usually blocked by the left lobe of the liver.
An effective liver retraction is important for good vision and safety during operation.
In this study, 120 patients who are over 18 years old with laparoscopic sleeve gastrectomy will be included.
4 groups will be formed and each group will be planned to include 30 patients.
In group 1, a 5 mm incision was made under xiphoid during the operation, and Nathanson retractor was placed and liver left lobe retraction would be achieved.
In the second group, a snake retractor with a 5 mm incision under the xiphoid will be used.
In the 3rd group, liver retraction will be provided by using a 5 mm trocar from the intersection of the right midclavicular line.
In the group, liver retraction through a 5 mm trocar entrained from the intersection of the right midclavicular line and a 4 cm superior umbilicus will be provided with the aid of laparoscopic grasper without any special tools.
In these patients, aspartate aminotransferase, alanine aminotransferase and Bilirubin levels will be examined on the postoperative 1st, 2nd and 3rd days and the patients will be examined with postoperative first day abdominal abdomen magnetic resonance imaging and the liver injury will be evaluated by the radiologist.
Patients will not know which liver excision method is used during surgery.
The radiologist who will perform damage assessment on imaging will not know which type of liver dislocation is used.
Therefore, the study will be planned as double blind.
The liver excision method will be applied sequentially.
Randomization will be done in this way.
Study Type
Interventional
Enrollment (Actual)
4
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Istanbul, Turkey, 34734
- fatih sultan mehmet research and training hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 66 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- The patients older than 18 years planned for Laparoscopic Sleeve Gastrectomy
Exclusion Criteria:
- The patients with liver failure
- The patients with impaired preoperative liver function tests
- The patients who have been diagnosed with any liver disease
- The patients with bleeding disorders
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Nathanson retractor
Liver retraction in group 1, a 5 mm incision was made under xiphoid during the operation, and Nathanson retractor was placed and liver left lobe retraction would be achieved.
|
liver retractor will be used for the retraction of left lobe of liver
Other Names:
|
|
Active Comparator: snake retractor
Liver retraction in group 2 ; 5 mm incision under the xiphoid will be used.
Snake retractor was placed and liver left lobe retraction would be achieved.
|
liver retractor will be used for the retraction of left lobe of liver
|
|
Active Comparator: fan retractor
Liver retraction in group 3 ; through a 5 mm trocar entrained from the intersection of the right midclavicular line and a 4 cm superior umbilicus
|
liver retractor will be used for the retraction of left lobe of liver
|
|
Active Comparator: CONTROL GROUP
Liver retraction in group 4 ; through a 5 mm trocar entrained from the intersection of the right midclavicular line and a 4 cm superior umbilicus will be provided with the aid of laparoscopic grasper without any special tools
|
laparoscopic grasper without any special tools
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Liver damage of liver retractors by measurement of AST(Aspartate Aminotransferase), ALT (alanine aminotransferase) , GGT (Gamma-Glutamyl Transferase) , Bilirubin (Total , direct , indirect ) levels.
Time Frame: 72 hours
|
measurement of AST(Aspartate Aminotransferase), ALT (alanine aminotransferase) , GGT (Gamma-Glutamyl Transferase) , Bilirubin (Total , direct , indirect ) levels will be measured preoperatively and postoperative 0 , 1 , 2 , 3 days and record.
|
72 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2019
Primary Completion (Actual)
January 1, 2020
Study Completion (Actual)
February 1, 2021
Study Registration Dates
First Submitted
January 2, 2019
First Submitted That Met QC Criteria
January 7, 2019
First Posted (Actual)
January 8, 2019
Study Record Updates
Last Update Posted (Actual)
March 23, 2021
Last Update Submitted That Met QC Criteria
March 19, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ANIL ERGIN.......
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Liver Damage
-
Instituto de Investigacion Sanitaria La FeUnknown
-
Omnia Saad Desoky MohamedNot yet recruiting
-
ShuGuang HospitalUnknown
-
University of MagdeburgSirtex MedicalCompletedColorectal Cancer | Liver Metastases | Irradiation Damage | Radiation Induced Liver DiseaseGermany
-
Columbia UniversityCompleted
-
University of ThessalyCompletedAthletic Performance | Muscle Damage | Skeletal Muscle DamageGreece
-
Makerere UniversityCompletedSepsis | Septic Shock | Acute Liver Failure | Head Injury | Post-cardiac Surgery | Post-Cardiorespiratory Arrest Coma | Hypoxic Brain Damage | Diabetic Ketoacidotic Hyperglycaemic Coma
-
Bispebjerg HospitalSygehus LillebaeltActive, not recruitingDNA Damage | Ultraviolet Rays; Injury | DNA Adduct Formation | DNA Damage, Radiation InducedDenmark
-
Ente Ospedaliero Cantonale, BellinzonaRecruitingCartilage DamageSwitzerland
-
University of ZagrebUniversity of Split, School of MedicineRecruiting
Clinical Trials on liver retraction Nathanson retractor
-
Umraniye Education and Research HospitalUnknown
-
Thomas Jefferson UniversityApple Medical CorporationUnknownObesity | Cesarean SectionUnited States
-
Nucleo De Pesquisa E Desenvolvimento De Medicamentos...Completed
-
Duke UniversityVirtual PortsWithdrawnLaparoscopic Sleeve Gastrectomy | Minimally Invasive Surgical Procedure | Laparoscopic Gastric Banding | Laparoscopic Roux-en-Y Gastric Bypass | Laparoscopic Fundoplication Procedure | Laparoscopic Heller Myotomy | Laparoscopic Paraesophageal Hernia Repair | Laparoscopic Gastric ResectionUnited States
-
Boehringer Labs LLCRecruiting